Reuters logo
BRIEF-Aurinia Pharmaceuticals announces Voclosporin results from Japanese Phase I study
February 14, 2017 / 12:17 PM / 7 months ago

BRIEF-Aurinia Pharmaceuticals announces Voclosporin results from Japanese Phase I study

Feb 14 (Reuters) - Aurinia Pharmaceuticals Inc

* Aurinia Pharmaceuticals Inc announces results from Japanese Phase I ethnic bridging study for Voclosporin

* Aurinia Pharmaceuticals Inc - data support continued development of Voclosporin in Japanese patient population

* Aurinia Pharmaceuticals Inc - there were no unusual or unexpected safety signals in study.

* Aurinia - PK parameters in Japanese patients were generally consistent with previously evaluated PK parameters in non-Japanese volunteers

* Aurinia Pharmaceuticals Inc says to share findings of study with Japanese pharmaceuticals, medical devices agency in Q2, Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below